A 7 gene expression score predicts for radiation response in cancer cervix

BMC Cancer

Volumn 9, Issue , 2009, Pages 365-

  Rajkumar, Thangarajan ^a   Vijayalakshmi, Neelakantan ^a   Sabitha, Kesavan ^a   Shirley, Sundersingh ^a   Selvaluxmy, Ganesharaja ^a   Bose, Mayil V ^a   Nambaru, Lavanya ^a  

^a CANCER INSTITUTE WIA   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CCL18 CHEMOKINE; CHEMOKINE; COLON TUMOR ANTIGEN 8; FOLLISTATIN; IRIDIUM 192; RNA; SOMATOMEDIN BINDING PROTEIN 2; STROMELYSIN; TUMOR ANTIGEN; UBIQUITIN CONJUGATING ENZYME E2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENETIC SELECTION; HUMAN; HUMAN TISSUE; LINEAR ACCELERATOR; MICROARRAY ANALYSIS; PREDICTION; RADIATION RESPONSE; RISK ASSESSMENT; RNA ANALYSIS; RNA HYBRIDIZATION; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TREATMENT FAILURE; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER;

EID: 70449719006     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-365     Document Type: Article

References (39)

1. Ashford L, Collymore Y, Boyd AR, Herdman C, Sherris J. Preventing cervical cancer worldwide, a joint report, with an accompanying policy brief produced by the Population Reference Bureau (PRB) and Alliance for Cervical Cancer Prevention (ACCP) 2004. Population Reference Bureau, Washington DC, USA.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108. 10.3322/canjclin.55.2.74, 15761078.
3. zur Hausen H. Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000, 92:690-8. 10.1093/jnci/92.9.690, 10793105.
4. Arends MJ, Buckley CH, Wells M. Aetiology, pathogenesis, and pathology of cervical neoplasia. J Clin Pathol 1998, 51:96-103. 10.1136/jcp.51.2.96, 500501, 9602680.
5. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. Cervical cancer. V.1.2009 , http://www.nccn.org
6. Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, Wolmark N. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004, 351:2817-26. 10.1056/NEJMoa041588, 15591335.
7. Vijayalakshmi N, Selvaluxmi G, Mahji U, Rajkumar T. C-myc oncoprotein expression and prognosis in patients with carcinoma of the cervix: an immunohistochemical study. Eur J Gynaecol Oncol 2002, 23:135.
8. Rajkumar T, Sharmila R, Majhi U, Selvaluxmi G, Vasanthan A, Shanta V. Bcl-2 and p53 expression in stage IIB and IIIB cervical cancers. Eur J Gynecol Oncol 1998, 19:556-560.
9. Bachtiary B, Schindl M, Pötter R, Dreier B, Knocke TH, Hainfellner JA, Horvat R, Birner P. Overexpression of hypoxia-inducible factor 1alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer. Clin Cancer Res 2003, 9:2234-40. 10.2152/jmi.55.78, 12796391.
10. Kawanaka T, Kubo A, Ikushima H, Sano T, Takegawa Y, Nishitani H. Prognostic significance of HIF-2alpha expression on tumor infiltrating macrophages in patients with uterine cervical cancer undergoing radiotherapy. J Med Invest 2008, 55:78-86. 10.1046/j.1525-1500.1998.00771.x, 18319549.
11. Nakano T, Oka K, Ishikawa A, Morita S. Immunohistochemical prediction of radiation response and local control in radiation therapy for cervical cancer. Cancer Detect Prev 1998, 22:120-8. 10.1038/sj.neo.7900251, 9544432.
12. Kitahara O, Katagiri T, Tsunoda T, Harima Y, Nakamura Y. Classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarray analysis. Neoplasia 2002, 4:295-303. 1531706, 12082545, 10.1038/sj.neo.7900251.
13. Wong YF, Selvanayagam ZE, Wei N, Porter J, Vittal R, Hu R, Lin Y, Liao J, Shih JW, Cheung TH, Lo KW, Yim SF, Yip SK, Ngong DT, Siu N, Chan LK, Chan CS, Kong T, Kutlina E, McKinnon RD, Denhardt DT, Chin KV, Chung TK. Expression genomics of cervical cancer: molecular classification and prediction of radiotherapy response by DNA microarray. Clin Cancer Res 2003, 9:5486-92.
14. Klopp AH, Jhingran A, Ramdas L, Story MD, Broadus RR, Lu KH, Eifel PJ, Buchholz TA. Gene expression changes in cervical squamous cell carcinoma after initiation of chemoradiation and correlation with clinical outcome. Int J Radiat Oncol Biol Phys 2008, 71:226-36. 10.1099/0022-1317-76-4-1057, 18406887.
15. de Roda Husman AM, Walboomers JM, Brule AJ, Meijer CJ, Snijders PJ. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995, 76:1057-62. 10.1128/JCM.42.7.3176-3184.2004, 9049358.
16. Sotlar K, Diemer D, Dethleffs A, Hack Y, Stubner A, Vollmer N, Menton S, Menton M, Dietz K, Wallwiener D, Kandolf R, Bültmann B. Detection and typing of Human papillomavirus by E6 Nested Multiplex PCR. J Clin Microbiol 2004, 42:3176-3184. 10.1073/pnas.091062498, 446280, 15243079.
17. BRB-Array Tools version 3.7.0 Patch_1 developed by Dr. Richard Simon and Amy Peng Lam. , http://linus.nci.nih.gov/BRB-ArrayTools.html
18. Tusher V, Tibshirani R, Chu G. Significance analysis of microarrays applied to transcriptional responses to ionizing radiation. Proc Natl Acad Sci USA 2001, 98:5116-21. 10.1093/bioinformatics/btg345, 33173, 11309499.
19. Wright GW, Simon R. A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 2003, 19:2448-55. 10.1186/1471-2164-6-59, 14668230.
20. Dallas PB, Gottardo NC, Firth MJ. Gene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR - how well do they correlate?. BMC Genomics 2005, 6:59. 1142514, 15854232, 10.1186/1471-2164-6-59.
21. Kim TJ, Choi JJ, Kim WY, Choi CH, Lee JW, Bae DS, Son DS, Kim J, Park BK, Ahn G, Cho EY, Kim BG. Gene expression profiling for the prediction of lymph node metastasis in patients with cervical cancer. Cancer Sci 2008, 99:31-8.
22. Harima Y, Togashi A, Horikoshi K, Imamura M, Sougawa M, Sawada S, Tsunoda T, Nakamura Y, Katagiri T. Prediction of outcome of advanced cervical cancer to thermoradiotherapy according to expression profiles of 35 genes selected by cDNA microarray analysis. Int J Radiat Oncol Biol Phys 2004, 60:237-48. 10.1042/BC20040151, 15337562.
23. Yisraeli JK. VICKZ proteins: a multi-talented family of regulatory RNA-binding proteins. Biology of the Cell 2005, 97:87-96. 10.1042/BC20040151, 15601260.
24. Lu M, Nakamura RM, Dent ED, Zhang JY, Nielsen FC, Christiansen J, Chan EK, Tan EM. Aberrant expression of fetal RNA-binding protein p62 in liver cancer and liver cirrhosis. Am J Pathol 2001, 159:945-53. 10.1006/clim.2001.5048, 1850441, 11549587.
25. Zhang JY, Chan EK, Peng XX, Lu M, Wang X, Mueller F, Tan EM. Autoimmune responses to Mrna binding proteins p62 and Koc in diverse malignancies. Clin Immunol 2001, 100:149-56. 10.1006/clim.2001.5048, 11465943.
26. Gu L, Shigemasa K, Ohama K. Increased expression of IGF II mRNA-binding protein 1 mRNA is associated with an advanced clinical stage and poor prognosis in patients with ovarian cancer. Int J Oncol 2004, 24:671-8. 10.1002/gcc.20418, 14767552.
27. Narayan G, Bourdon V, Chaganti S, Arias-Pulido H, Nandula SV, Rao PH, Gissmann L, Dürst M, Schneider A, Pothuri B, Mansukhani M, Basso K, Chaganti RS, Murty VV. Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes. Genes Chromosomes Cancer 2007, 46:373-84. 10.1007/s10549-007-9673-x, 17243165.
28. Campone M, Campion L, Roché H, Gouraud W, Charbonnel C, Magrangeas F, Minvielle S, Genève J, Martin AL, Bataille R, Jézéquel P. Prediction of metastatic relapse in node-positive breast cancer: establishment of a clinicogenomic model after FEC100 adjuvant regimen. Breast Cancer Res Treat 2008, 109:491-501. 10.1007/s10549-007-9673-x, 17659439.
29. Donato G, Iofrida G, Lavano A, Volpentesta G, Signorelli F, Pallante PL, Berlingieri MT, Pierantoni MG, Palmieri D, Conforti F, Maltese L, Tucci L, Amorosi A, Fusco A. Analysis of UbcH10 expression represents a useful tool for the diagnosis and therapy of astrocytic tumors. Clin Neuropathol 2008, 27:219-23. 10.1074/jbc.M707117200, 18666437.
30. Eichberger T, Kaser A, Pixner C, Schmid C, Klingler S, Winklmayr M, Hauser-Kronberger C, Aberger F, Frischauf AM. GLI2-specific transcriptional activation of the bone morphogenetic protein/activin antagonist follistatin in human epidermal cells. J Biol Chem 2008, 283:12426-37. 10.1074/jbc.M803997200, 2430996, 18319260.
31. Chen M, Sinha M, Luxon BA, Bresnick AR, O'Connor KL. Integrin alpha6beta4 controls the expression of genes associated with cell motility, invasion, and metastasis, including S100A4/metastasin. J Biol Chem 2009, 284:1484-94. 10.1038/sj.bjc.6603543, 19011242.
32. Hagemann T, Bozanovic T, Hooper S, Ljubic A, Slettenaar VI, Wilson JL. Molecular profiling of cervical cancer progression. Br J Cancer 2007, 96:321-8. 10.1158/1078-0432.CCR-1116-03, 2360010, 17242701.
33. Blons H, Gad S, Zinzindohoué F, Manière I, Beauregard J, Tregouet D, Brasnu D, Beaune P, Laccourreye O, Laurent-Puig P. Matrix Metalloproteinase 3 Polymorphism: A Predictive Factor of Response to Neoadjuvant Chemotherapy in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res 2004, 10:2594-99. 10.1016/S0092-8674(00)81009-0, 15102660.
34. Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougier JP, Gray JW, Pinkel D, Bissell MJ, Werb Z. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 1999, 98:137-46. 10.1016/S0092-8674(00)81009-0, 10428026.
35. Struyf S, Schutyser E, Gouwy M, Gijsbers K, Proost P, Benoit Y, Opdenakker G, Van Damme J, Laureys G. PARC/CCL18 Is a Plasma CC Chemokine with Increased Levels in Childhood Acute Lymphoblastic Leukemia. Am J Pathol 2003, 163:2065-75. 10.1189/jlb.1204712, 1892433, 14578205.
36. Schutyser E, Richmond A, Van Damme J. Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes. J Leukoc Biol 2005, 78:14-26. 10.1002/(SICI)1097-0215(19980529)76:5<652::AID-IJC7>3.0.CO;2-P, 2665283, 15784687.
37. Scanlan MJ, Chen YT, Williamson B, Gure AO, Stockert E, Gordan JD, Türeci O, Sahin U, Pfreundschuh M, Old LJ. Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer 1998, 76:652-8. 10.1158/0008-5472.CAN-05-0669, 9610721.
38. Erkanli A, Taylor DD, Dean D, Eksir F, Egger D, Geyer J, Nelson BH, Stone B, Fritsche HA, Roden RB. Application of Bayesian modeling of autologous antibody responses against ovarian tumor-associated antigens to cancer detection. Cancer Res 2006, 66:1792-8. 10.1016/S0378-1119(02)01141-1, 16452240.
39. Kenedy AA, Cohen KJ, Loveys DA, Kato GJ, Dang CV. Identification and characterization of the novel centrosome-associated protein CCCAP. Gene 2003, 303:35-46. 10.1016/S0378-1119(02)01141-1, 12559564.